Twin Peaks Wealth Advisors’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Twin Peaks Wealth Advisors's CLB Position: Q2 2026 in Review
Twin Peaks Wealth Advisors sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 265 shares — an estimated $4.45K sold.
Twin Peaks Wealth Advisors first reported a position in CLB in Q1 2026 and held it in 1 quarter. The position peaked at $4.45K in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Twin Peaks Wealth Advisors reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
- Twin Peaks Wealth Advisors sold 265 Core Laboratories shares in Q2 2026, an estimated $4.45K.
- Twin Peaks Wealth Advisors first reported a position in Core Laboratories in Q1 2026 and held it in 1 quarter.
- Twin Peaks Wealth Advisors's Core Laboratories position peaked at $4.45K in Q1 2026.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.